Aquestive Therapeutics, Inc.(AQST)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
AQST has no upcoming report date in the calendar yet. It last reported on Nov 3, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±7.7%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 5 misses.
In plain words: it beat expectations 5 times, but the stock still fell 2 of those 5 times.
- May '26Beat▲ +14.5%
- Mar '26Missed▼ -2.5%
- Aug '25Beat▼ -2.1%
- May '25Missed▼ -19.6%
- Mar '25Missed▼ -7.5%
- Nov '24Beat▼ -7.7%
- Aug '24Beat▲ +0.9%
- May '24Missed▼ -8.7%
- Mar '24Missed▲ +20.0%
- Nov '23Beat▲ +4.9%
Clear beats and misses with a known reaction only. What counts as a beat
Why did AQST fall after beating earnings?
3 of AQST's last 10 reactions went against the EPS result. What stands out in each:
AQST beat EPS estimates in 5 quarters, and the stock still closed lower the next day 2 times.
- Aug 11, 2025EPS beat +29.4%stock -2.1% next day
- It opened 3.1% higher, but sellers took over and it closed -2.1%.
- Nov 4, 2024EPS beat +8.3%stock -7.7% next day
- It had risen 6.2% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.9% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 5)
- Mar 5, 2024EPS missed -28.6%stock +20.0% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was AQST's earnings move already priced in?
AQST's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does AQST hold its opening gap after earnings?
AQST's opening move after each report and where it closed that day.
In 12 reports AQST opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 12 times (42%), and fully reversed 2 times. Gaps up faded 3 of 5; gaps down recovered 2 of 7.
- Nov 3, 2026FadedOpened -5.7%, closed -2.1%
- May 13, 2026HeldOpened +15.0%, closed +14.5%
- Mar 4, 2026HeldOpened -2.5%, closed -2.5%
- Nov 5, 2025FadedOpened +8.0%, closed +2.2%
- Aug 11, 2025ReversedOpened +3.1%, closed -2.1%
- May 12, 2025HeldOpened -10.2%, closed -19.6%
- Mar 5, 2025HeldOpened -11.8%, closed -7.5%
- Nov 4, 2024HeldOpened -2.9%, closed -7.7%
What the history says
- It fell after 2 of its 5 EPS beats (40%): beating estimates has not been enough on its own.
AQST earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | Revenue surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | After close | -$0.13 | -$0.11 | sources differ | -32.7% | -2.06% | — |
| May 13, 2026 | After close | -$0.13 | -$0.05 | +61.5% | — | +14.53% | +0.12% |
| Mar 4, 2026 | After close | -$0.12 | -$0.14 | -16.7% | — | -2.52% | -1.83% |
| Nov 5, 2025 | After close | -$0.11 | -$0.11 | 0.0% | — | +2.17% | -7.00% |
| Aug 11, 2025 | After close | -$0.17 | -$0.12 | +29.4% | — | -2.07% | +6.48% |
| May 12, 2025 | After close | -$0.16 | -$0.22 | -37.5% | — | -19.65% | -16.49% |
| Mar 5, 2025 | After close | -$0.13 | -$0.16 | -23.1% | — | -7.53% | -8.96% |
| Nov 4, 2024 | After close | -$0.12 | -$0.11 | +8.3% | — | -7.67% | -1.36% |
| Aug 6, 2024 | After close | -$0.11 | -$0.01 | +90.9% | — | +0.88% | +0.88% |
| May 7, 2024 | After close | -$0.10 | -$0.15 | -50.0% | — | -8.73% | -8.58% |
| Mar 5, 2024 | After close | -$0.07 | -$0.09 | -28.6% | — | +20.05% | +16.47% |
| Nov 6, 2023 | After close | -$0.11 | -$0.03 | +72.7% | — | +4.91% | +4.91% |
AQST Earnings FAQ
Answers computed from Aquestive Therapeutics, Inc.'s reported history
AQST has no upcoming report date in the calendar yet. It last reported on Nov 3, 2026; companies usually report every three months.
Over the last 11 quarters with a usable EPS surprise, AQST beat the consensus estimate 5 times (46%), missed 5 and landed in line 1. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.
Across its last 12 quarters with a measured reaction, AQST moved an average of ±7.7% in the first session after reporting. It closed higher 42% of the time; the largest gain was 20.1% and the largest drop -19.7%.
AQST fell in the first session after 2 of its last 5 EPS beats (40%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 12 quarters with price data, AQST moved an average of +7.7% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (6 quarters), it fell the next day 50% of the time, averaging -0.7%. After a drop of 3% or more (5 quarters), it rose the next day 20% of the time, averaging -3.6%. This describes past reports; it is not a forecast.
In 12 reports AQST opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 12 times (42%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · AQST: 12 reported quarters, latest Nov 3, 2026. Information only, not investment advice.
Looking for more on AQST?
Price charts, forecast, fundamentals and risk pages for AQST are not on Tickzen yet. You can run a full stock analysis now.
Run the AQST Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun